Tideglusib
Tideglusib is under the investigation for the development of treatments for Alzheimer's disease and for progressive supranuclear palsy. Reference standards of Tideglusib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Tideglusib - API Standards
[catalogue_number] => PA 73 38000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 334.39
[form] => C19H14N2O2S
[cas] => 865854-05-3
[pslug] => 865854-05-3-tideglusib-api-pa7338000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Tideglusib - API Standards
Catalogue No.:PA 73 38000
Molecular Formula : C19H14N2O2S
Molecular Weight : 334.39